Novel use of sildenafil in the management of pulmonary hypertension due to post-catheter ablation 'stiff left atrial syndrome'

Int J Cardiol. 2015 Feb 15:181:55-6. doi: 10.1016/j.ijcard.2014.12.012. Epub 2014 Dec 3.

Authors

Geoffrey R Wong¹, Dennis H Lau¹, Timothy J Baillie¹, Melissa E Middeldorp¹, Peter M Steele¹, Prashanthan Sanders²

Affiliations

¹ Centre for Heart Rhythm Disorders (CHRD), South Australian Health and Medical Research Institute (SAHMRI), University of Adelaide and the Royal Adelaide Hospital, Adelaide, Australia.
² Centre for Heart Rhythm Disorders (CHRD), South Australian Health and Medical Research Institute (SAHMRI), University of Adelaide and the Royal Adelaide Hospital, Adelaide, Australia. Electronic address: prash.sanders@adelaide.edu.au.

PMID: 25482279
DOI: 10.1016/j.ijcard.2014.12.012

No abstract available

Keywords: Atrial fibrillation; Catheter ablation; Pulmonary hypertension; Sildenafil; Stiff left atrial syndrome.

Publication types

Case Reports
Letter
Research Support, Non-U.S. Gov't

MeSH terms

Aged
Atrial Fibrillation / therapy
Biological Availability
Catheter Ablation / adverse effects*
Catheter Ablation / methods
Echocardiography
Female
Heart Atria / physiopathology*
Humans
Hypertension, Pulmonary / diagnosis
Hypertension, Pulmonary / drug therapy*
Hypertension, Pulmonary / etiology
Hypertension, Pulmonary / physiopathology
Pulmonary Wedge Pressure / drug effects
Sildenafil Citrate* / administration & dosage
Sildenafil Citrate* / pharmacokinetics
Treatment Outcome
Vasodilator Agents / administration & dosage
Vasodilator Agents / pharmacokinetics

Substances

Vasodilator Agents
Sildenafil Citrate